Lisata Therapeutics, Inc. (LSTA) NASDAQ

Currency In USD

AD

Valuation

Market Cap16.16M
Enterprise Value201,820
P/E Ratio-1.89
PEG Ratio-0.09
Price/Sales Ratio188.56
Price/Book Ratio2.9
Enterprise/Revenue111.73
Enterprise/EBITDA-1.14

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-96.18
Operating Margin-101.78
AD

Management Effectiveness

Return On Assets-1.16
Return On Equity-1.02

Income Statement

Revenue170,000
Revenue/Share0.02
Gross Profit24,000
EBITDA-17.4M
Net Income-16.59M
Diluted EPS-1.91

Balance Sheet

Total Cash13.06M
Total Cash/Share1.45
Total Debt0
Total Debt/Equity0
Current Ratio4.23
Book Value Per Share1.18

Price History

52-Week Change47.28
52-Week High5.07
52-Week Low1.81
Moving Average 50 Days3.44
Moving Average 200 Days3.18

Statistics

Average Volume115,241
Shares Outstanding9.11M
% Held by Institutions12.18

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateSeptember 15, 2022
AD